Boxed Warning Removed From LABA/ICS Combination Asthma Medications: FDA

New evidence regarding safety is spurring the U.S. Food and Drug Administration to remove a Boxed Warning from certain inhaled medications used to treat asthma and chronic obstructive pulmonary disease (COPD).
The decision applies to a class of…
Source: Topamax